Globus Medical Director Files Intent to Sell $2.15M in Stock
GLOBUS MEDICAL INC
Subscribe to track GMED
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Globus Medical Director Files Intent to Sell $2.15M in Stock
Company: GLOBUS MEDICAL INC (GMED) Form: 144 | Filed: 2025-11-12 Significance: Low
Insider: Davidar David D Title: Director | Relationship: Director
Transaction: • Type: Proposed Sale (via Cashless Option Exercise) • Shares: 25,000 • Price: $85.95 • Value: $2,148,750 • Owned After: Not Disclosed
Key Insight: A director has filed a notice of a proposed sale of shares valued at approximately $2.15 million. The transaction size is very small relative to the company's market capitalization, representing less than 0.02% of the market cap and shares outstanding.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: GLOBUS MEDICAL INC (GMED)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director at Globus Medical has filed a notice of intent to sell 25,000 shares, valued at approximately $2.15 million, which were acquired through a cashless option exercise.
- Market Impact: The transaction is considered immaterial and is unlikely to have a noticeable impact on the stock, given its small size relative to the company's large market capitalization.
Company Information
| Field | Value |
|---|---|
| Company | GLOBUS MEDICAL INC |
| Ticker Symbol | GMED |
| CIK | 0001237831 |
| Industry | Surgical & Medical Instruments & Apparatus |
Insider Information
| Field | Value |
|---|---|
| Name | Davidar David D |
| CIK | 0001555268 |
| Title/Position | Director |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 |
| Transaction Date | 2025-11-12 |
| Transaction Code | S (Proposed Sale) |
| Security Type | Common Stock |
| Shares Involved | 25,000 |
| Price Per Share | $85.95 |
| Total Value | $2,148,750 |
| Shares Owned After | Not Disclosed |
| Ownership Type | Not Disclosed |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $2,148,750 |
| % of Market Cap | 0.019% |
| Shares Transacted | 25,000 |
| % of Shares Outstanding | 0.019% |
| Post-Transaction Ownership | Not Disclosed |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The $2.15 million sale is negligible for a company with an $11.56 billion market capitalization. Such transactions are routine and do not signal a significant change in insider sentiment.
- Transaction Significance: Based on the transaction constituting less than 0.02% of both market cap and shares outstanding, its significance is low. It does not meet the thresholds for moderate or high significance.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The sale is too small to be considered a material event for a large-cap company like Globus Medical. It is likely part of a planned financial strategy by the director and does not imply a negative outlook on the company's future.
Volume & Sentiment
- Expected Volume Impact: Minimal. The transaction size is unlikely to cause any unusual trading volume.
- Sentiment Indicator: Neutral. The market will likely view this as a routine, non-eventful insider transaction.
Additional Context
Transaction Notes
- The filing is a Form 144, which is a notice of proposed sale of securities. The sale is related to a cashless option exercise, a common method for insiders to realize value from their equity compensation.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
